Adherence to oral endocrine therapy in adjuvant breast cancer settings is a substantial
clinical problem. To provide current perspective on adherence to oral endocrine therapies, a …

Simple Summary Endocrine therapy taken after primary breast cancer treatment helps
prevent breast cancer recurrence. However, many women are unable to adhere to …

Cytochrome P450s are key players in drug metabolism, and overexpression in tumors is
associated with significant resistance to many medicinal agents. Consequently, inhibition of …

Background Adjuvant endocrine therapy (AET) significantly decreases the risk of breast
cancer recurrence and mortality. Notwithstanding the demonstrated efficacy of AET, 31–73 …

Purpose To explore how symptoms and psychosocial factors are related to intentional and
unintentional non-adherent medication taking behaviors. Methods Included were …

Adjuvant hormone therapy contributes to reductions in recurrence and mortality for women
with hormone receptor–positive breast cancer. However, adherence to hormone therapy is …

Purpose To examine factors associated with non-adherence during 5 years of endocrine
treatment, including the possible influence of comorbidity burden and specific medical …

Impact of patient race and geographical factors on initiatio... : Medicine Impact of patient race
and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare …

Objectives Tamoxifen non‐adherence is apparent in up to half of breast cancer survivors
and is associated with increased risk of recurrence and reduced quality of life. However …

Mobile health systems aiming to promote adherence may cost-effectively improve the self-
management of chronic diseases like diabetes, enhancing the compliance to the medical …